Search

everythinglearnresearchcommunity

for

Search:↓

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Baricitinib was effective in treating both early and late onset alopecia areata.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Leukemia should be considered in teens with unexplained bleeding.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.